These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11793610)

  • 1. [Primary prevention of cardiovascular events by ASS and vitamin E. PPP--Primary Prevention Project].
    Nordt T
    Internist (Berl); 2001 Dec; 42(12):1705-7. PubMed ID: 11793610
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial.
    Sacco M; Pellegrini F; Roncaglioni MC; Avanzini F; Tognoni G; Nicolucci A;
    Diabetes Care; 2003 Dec; 26(12):3264-72. PubMed ID: 14633812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of stroke with aspirin, vitamin E is ineffective].
    Stiefelhagen P
    Med Monatsschr Pharm; 2005 Jul; 28(7):249-50. PubMed ID: 16038126
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
    N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin in primary prevention.
    Pyrgakis VN
    Hellenic J Cardiol; 2009; 50(5):441-2. PubMed ID: 19767291
    [No Abstract]   [Full Text] [Related]  

  • 6. Meta-analysis of data from the six primary prevention trials of cardiovascular events using aspirin.
    Bartolucci AA; Howard G
    Am J Cardiol; 2006 Sep; 98(6):746-50. PubMed ID: 16950176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin for primary prevention of cardiovascular and all-cause mortality events in diabetes: updated meta-analysis of randomized controlled trials.
    Kunutsor SK; Seidu S; Khunti K
    Diabet Med; 2017 Mar; 34(3):316-327. PubMed ID: 27086572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylsalicylic acid and vitamin E in prevention of arterial thrombosis.
    Polasek J
    Can J Cardiol; 1997 May; 13(5):533-5. PubMed ID: 9179093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin Plus Clopidogrel vs Aspirin Alone for Preventing Cardiovascular Events Among Patients at High Risk for Cardiovascular Events.
    Donadini MP; Bellesini M; Squizzato A
    JAMA; 2018 Aug; 320(6):593-594. PubMed ID: 30054611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin for the prevention of cardiovascular disease.
    Lin KW
    Am Fam Physician; 2011 Jun; 83(12):1469-70. PubMed ID: 21671548
    [No Abstract]   [Full Text] [Related]  

  • 11. Aspirin for the prevention of cardiovascular disease: recommendation statement.
    Am Fam Physician; 2011 Jun; 83(12):1464-8. PubMed ID: 21671547
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.
    Berger JS; Roncaglioni MC; Avanzini F; Pangrazzi I; Tognoni G; Brown DL
    JAMA; 2006 Jan; 295(3):306-13. PubMed ID: 16418466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials.
    Sanmuganathan PS; Ghahramani P; Jackson PR; Wallis EJ; Ramsay LE
    Heart; 2001 Mar; 85(3):265-71. PubMed ID: 11179262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin prevents stroke but not MI in women; vitamin E has no effect on CV disease or cancer.
    Buring JE
    Cleve Clin J Med; 2006 Sep; 73(9):863-70. PubMed ID: 16970138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The puzzle of aspirin and sex.
    Levin RI
    N Engl J Med; 2005 Mar; 352(13):1366-8. PubMed ID: 15755763
    [No Abstract]   [Full Text] [Related]  

  • 16. Aspirin in the treatment and prevention of cardiovascular disease: current perspectives and future directions.
    Hennekens CH
    Curr Atheroscler Rep; 2007 Nov; 9(5):409-16. PubMed ID: 18001625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin.
    Bartolucci AA; Tendera M; Howard G
    Am J Cardiol; 2011 Jun; 107(12):1796-801. PubMed ID: 21481826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Female, young, healthy. ASS does not protect from myocardial infarct].
    MMW Fortschr Med; 2005 Mar; 147(12):10. PubMed ID: 15832782
    [No Abstract]   [Full Text] [Related]  

  • 19. The aspirin controversy in primary prevention.
    Raju NC; Eikelboom JW
    Curr Opin Cardiol; 2012 Sep; 27(5):499-507. PubMed ID: 22874127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin E, a modifier of platelet function: rationale and use in cardiovascular and cerebrovascular disease.
    Steiner M
    Nutr Rev; 1999 Oct; 57(10):306-9. PubMed ID: 10575906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.